Bit Capital Gmb H Leap Therapeutics, Inc. Transaction History

Bit Capital Gmb H

  • $1.26 Trillion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Feb 12, 2025
BUY
$0.29 - $0.72 $50,207 - $124,652
173,129 Added 47.19%
540,000 $184 Million
Q4 2022

Feb 12, 2025
BUY
$0.42 - $9.18 $135,278 - $2.96 Million
322,091 Added 719.27%
366,871 $165 Million
Q3 2022

Feb 12, 2025
BUY
$0.92 - $9.3 $41,197 - $416,454
44,780 New
44,780 $39.4 Million

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0
View Full List

About LEAP THERAPEUTICS, INC.

LPTX Quotes by TradingView
  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $47.5M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Bit Capital Gmb H Portfolio

Follow Bit Capital Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Bit Capital Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email